This paper attempts to examine use and dependent measures for exclusive cigarette smokers, ENDS users, and dual-users (ENDS and cigarettes) in a convenience sample of American Indians living in the Southern plains region of the United States. As mentioned in the discussion section, the term "Southern Plains" is really incorrect for the current study and may actually encompass many more cultural and tribal groups than are represented by sampling in Oklahoma alone. I assume that this may have been done in an attempt to demonstrate that this population would fall into the "Southern Plains" category of tobacco prevalence mentioned in the introduction. However, I would suggest sticking with "American Indians residing in Oklahoma" for further description -particularly because that offers more of a specific geographic portrayal to the reader. Since the state has a very large population of American Indian residents, this feels like a much more accurate and meaningful report. The study states its purpose as addressing the lack of literature on ENDS use among American Indians by describing sociodemographic and lifestyle characteristics, secondhand smoke exposure, use behaviors and dependence among exclusive ENDS users, exclusive smokers, and dual users. The manuscript does not provide much detail on some of these items (lifestyle characteristics?). However, several interesting findings could be refined.
Overall suggestions would be to remove the sections discussing "degree of Indian blood", all secondhand smoke (SHS) measures and other non-significant results, and instead focusing more heavily on fully discussing all findings within the context of an exploratory study. Since this is a study looking primarily at the use of ENDS by American Indian tobacco users, SHS feels like too distinctly different of a research question. Many of the variables could use a much stronger justification for why they were included as measurements. It seems that the authors are considering exclusive smoking, dual use, and ENDS use to all be equally harmful activities. It would be helpful to see a recognition of what exactly dual use means, and why this would potentially be more dangerous than ENDS use alone, for example.
Finally, much of the discussion section would be more appropriate for the results (findings should not appear for the first time in the discussion section), and more detail could be given to the choices of assessment techniques (using PATH description for ENDS use; HONC for autonomy over cigarettes, etc.). Because there are so many wide-ranging research questions asked here, the study would benefit from stronger transitions throughout that work to create a more cohesive picture of what commercial tobacco use is like among this population.
Introduction:
• The authors correctly point out that this population experiences the greatest smoking rates of any racial/ethnic group in the United States. The study then immediately jumps into discussions of electronic cigarettes, without really explaining why they might be particularly relevant to tobacco users. There is some justification for believing that ENDS use rates might also be higher among this population, but little done to make the logical connection between higher rates of tobacco use and higher rates of ENDS usage. The case for the importance of the study would be strengthened if this connection was made more explicit.
• The references for regional tobacco use rates are rather outdated… is there no newer data available? • I would recommend against using the word "deemed" regarding the FDA and ENDS… particularly because this is an international journal, I'm not sure that the reader would immediately have the familiarity to know what this means.
• It would be worthwhile to provide a bit of context around why smoking and commercial tobacco rates are so much higher in Native populations.
• The first couple of sentences in paragraph 3 are rather confusing. Please consider rewording.
• The paper refers to itself as "descriptive" several times in the methods and results, but seems to make larger claims about impact in the abstract and discussion sections (addressing the lack of literature; informing the FDA). Exploratory studies with small sample sizes (such as this one) are perfectly valid, but the description of it as such should be consistent.
Methods:
• Inclusion criteria is interesting… is there a reason for not trusting self-identification as AI? Having two biological grandparents might be a restricting factor, as many individuals may have parents/grandparents who were forced into adoption, etc.
• Was there a rationale for starting the cut-off at 10 CPD vs., 5 or even daily smoking? This may ultimately have an impact on the type of dual users that participate. There is no concern with 10 as the cutoff, but it might be helpful to add a supporting cite or brief statement on why this number was chosen for readers.
• I'm very unclear on the need to identify "degree of Indian blood"… if this were being used as part of a large biomarker study (which the authors seem to suggest they intend to do at another point) it might make sense, but as it is written, it feels fairly out of place and potentially problematic to include.
• The combination of ENDS description from the PATH survey, combined with the Ontario description of what constitutes "using" an ENDS product was a good choice.
• The HONC screening tool is an interesting choice… using this over more widely used methods (i.e. Fagerstrom Test for Nicotine Dependence) would have been more helpful to include here, versus the discussion section.
• Why is the criteria for CO level different for ENDS users vs. cigarette smokers? A sentence or so explaining this would be helpful to help the reader better understand.
Results:
• The HONC screening tool is looking for level of autonomy over cigarettes, but you often refer to these results as being indicative of level of addiction/dependence. Are those synonymous? It would be helpful to include whether there have been previous studies to validate that these two items (loss of autonomy and dependence) are in fact correlated. If they are not, language should be carefully used to avoid giving the impression that they are one in the same.
• What does "traditional tobacco" mean in Table 1 ? If this is referring to the use of sacred tobacco, that should be clarified since it is not mentioned or explained elsewhere (this is especially important given that this is not a tobacco-focused journal and is international in scope). If it is referring to cigarette use, that needs to be explicitly stated.
• Again, I am very confused by the inclusion of "Indian blood quantum" or "percent Indian-ness" as it is included in the results. This doesn't feel relevant for the purposes of the study's findings (and certainly doesn't seem consistent with what the study intended to examine). In fact, the inclusion here raises more questions that are never answered. I suggest dropping these sections.
• I would suggest eliminating Table 2 , as it doesn't add significantly to the overall paper and only has one significant finding.
• The paper would be much easier to read if the results simply stated whether or not findings were significant and left the actual p-values to the tables.
• Additionally, p-values should be reported closer to the level of significance (versus including all of the decimal places currently listed).
• On all tables -it would be helpful to have visual recognition of significant results, and at what level (.001, .01, .05).
• There may be an issue with recall error in asking dual users to remember their CPD prior to starting ENDS use. This is addressed briefly in the discussion, but since the CPD portion of this paragraph (listed in Table 3 ) doesn't add much to the findings, I suggest dropping it. This same issue comes up again in the discussion (pg. 16).
Discussion:
• SHS exposure -were the individuals who were exposed at work living/working on reservations? In other words, are there reasons that their workplaces might not be covered by state smoke-free laws or protections? As I mentioned previously, I think that the SHS questions actually serve to distract from the focus of the paper, which seems to be ENDS use. I would recommend dropping this section.
• The statement on ENDS users and SHS exposure (being result of a supportive quitting environment) feels like a reach -even with the disclaimer that directionality is not known.
• Pg. 15, paragraph 2. 10 CPD considered to be low to moderate by what criteria? This needs a citation.
• There are many reasons that AI smokers may experience higher rates of death and disease that go far beyond their inhalation. This statement should be omitted -particularly since you are offering no evidence from this study or others to support it. Other (I would argue more likely) possibilities may be factors like structural racism, poverty, historical trauma, reduced access to preventative medicine or early detection, etc.
• Pg. 16 -be careful about saying "it is likely that …" regarding the motivations for ENDS use when you did not actually ask those questions. Your point is well-taken, but it may be better to say "one possibility for more quit attempts may be…"
• Much of the discussion section is actually introducing new results. Some of these items are included in tables, but not examined in the text. Examples are: ENDS flavors, "vape session" measurements, HONC measurements. o Consequently, the discrepancies in number of "vape sessions" is interesting and could have been discussed more thoroughly. The need for further cognitive testing around these items would also make a worthwhile recommendation for future research.
• I'm a bit confused at the more hard-line stance on ENDS taken in the discussion section and the need for the FDA to consider further regulation -particularly after your results seem to suggest that people might be using them to help quit smoking and the level of diminished autonomy is less for ENDS than for cigarettes.
• The HONC paragraph (pg. 18) feels inappropriate for the discussion section. A brief description of this method, your choice for using it, and potentially the measures should be in the introduction and/or methods sections.
• This paper would benefit from a separate "limitations" section.
REVIEWER
Deric Kenne Kent State University United States of America REVIEW RETURNED 31-Aug-2017
GENERAL COMMENTS
The current study is important because, as the authors point out, little information regarding ENDS use among American Indian populations is available. Filling this gap in the literature has the potential to address a growing public health concern both in terms of policy and program intervention.
I have several major concerns regarding the manuscript.
1. At times it is somewhat unclear what the purpose or emphasis of the paper was. For example, the abstract leads readers to believe that this is a descriptive study regarding the use of e-cigarettes and tobacco cigarettes among American Indians. However, the paper strays, I believe, at times when it discusses, "novel method for assessing dependence to ENDS…" or when the authors discuss how the present study is unique in the number of characteristics collected on ENDS devices.
2. The authors discuss several exclusionary criteria. While reasons for some exclusionary criteria seem commonsense (e.g., involvement in a cessation program), other exclusionary criteria seem overly strict (e.g., alcohol use within 24 hours, use of an ENDS every day for the past 3 months). The authors should provide explanations for why the various exclusionary criteria were used.
3. Under the section, "Biomedical assessment of smoking status," the authors provide rationale for including cigarette smokers and adequately cite prior research. However, the rationale behind selection of (or exclusion of) ENDS users is not clear. 6. In the Discussion, it is unclear why the discussion of exposure to tobacco cigarette smoke is included, or how exposure fits with the overall purpose and focus of the paper. Further, there is no discussion of existing research regarding tobacco smoke exposure and how it compares to the findings for this AI population.
7. On page 16, last paragraph, line 46 -53, the authors report, "The vast majority of ENDS and dual users reported using a tank or vapor system. Additionally, most reported that their ENDS was refillable with e-liquid and rechargeable…" It is unclear why this is presented to readers and more importantly, how it contributes to the overall focus of the study. While the information is interesting, it does not seem to match up with the purpose of the paper.
8. The discussion of methods of assessing dependence on page 18 -19, again, seems to stray from the originally defined purpose of the paper (e.g., characteristics and use patterns of ENDS among AI).
9. Did the authors control for age of participants, given that ENDS users tend to be much younger than tobacco or dual users? Age could impact several of the variables in the study (e.g., marital status, duration of use, etc.). Table 4 . Currently, the values are reported in the narrative, but not included in the table.
I suggest including p-values in
11. In the limitations section, the authors should also discuss the potential issues related cross sectional designs and recall bias.
REVIEWER
Associate Professor Marewa Glover Massey University New Zealand REVIEW RETURNED 01-Sep-2017
GENERAL COMMENTS
The study focused on a small sample of a specific sub-group of Amercian Indian people. For an international audience it would have been good if the authors had discussed if similar information had previously been collected with regards to other indigenous peoples. It is not enough to claim that the study "is informative" -the authors need to say how it is informative. What do they think their paper adds to existing knowledge or what does it contribute to answering existing questions?
The researchers asked questions they claimed would help them determine participants' "total degree of Indian blood." Why was this important? How valid was their measure for doing this? How appropriate is it to treat Indigenous people this way? In New Zealand, the blood quantum strategy for classifying people as more or less Indigenous was rejected long ago. It was an offensive measure used by the colonising peoples to deny Indigeneity, to claim that there were no full blood Māori left and therefore Māori rights and claims, enshrined in the Treaty of Waitangi and as recognised under internation Rights of Indigenous People's, were redundant. It also denies the Indigenous worldview and beliefs about how people are connected as family and tribes. It and does not recognise the spiritual beliefs of people. New Zealand mostly uses self-reported identity which respects people's sovereignty. The use of this measure by the researchers implies that they suspect there is some genetic or cultural difference that might be associated with smoking or vaping. If they think this, they should make it clear. What theories underpin their question realms?
Though the researchers collected this information on "degree of Indian blood" they did not discuss the result in the paper. It is reported that median duration of ENDS use was 2 years among ENDS users and 1 year among 'dual' users which supports proposals in other papers that some vapers transition over time from smoking and vaping to only vaping. The researchers need to access more of the literature on vaping to assist a more considered discussion section. Comments on the discussion. The authors state that the ability to quit cigarettes, among the ENDS users, may have resulted from their living in smoke-free homes. "Resulted" implies a causal effect. This should be changed to "helped" or "supported by". The statements made about dependency levels are followed tenuously by a statement that AI have higher levels of tobaccorelated disease. They go on to then imply that perhaps this is the case because of how AI smoke. This section should be deleted. It ignores the many established reasons why Indigenous people experience such shocking inequities in health -how they smoke a cigarette is not one of them. It is a victim-blaming deficit framing that ignores the broader history of colonisation, land loss, and economic and social determinants of health that contribute to disproportionately higher smoking rates. Instead of citing a report to back the claim that quit attempts are critical to increasing cessation rates, the authors should cite original research.
Other studies have found that people vape not only to quit smoking but also to cut down their tobacco smoking. This is not mentioned and yet some of their participants appear to have done this. The authors argue that future studies are needed to understand the impact of dual use on public health, including the potential to undermine prevention and cessation efforts. Why is this placed in the paper where it is, or at all? This is not prefaced as a concern in the introduction and it should have been. ENDS are not just part of the "diversifying tobacco landscape" but they are part of the "diversifying tobacco and nicotine use landscape". The authors claim that a major strength of their study was the "number of characteristics collected on ENDs use" but why is this a strength?
The authors refer to "concern surrounds flavoured tobacco products" but the concerns are unfounded are they not? Vaping is not smoking. The authors need to be careful that they do not conflate the two as they do when talking about the concerns about flavoured tobacco. They need to delete the phrase "not only reduce youth appeal" or reword to more accurately represent the state of knowledge on this. The literature strongly suggests that prohibiting the use of flavoured nicotine eliquid will reduce the appeal of vaping to smokers and cessation efficacy. One limitation of the study is the use of an unvalidated and potentially misleading measure of vapour consumption. Further, as they suspect the wording of some of the questions about vaping sessions relied on retrospective recall which is typically a weak tool with poor validity. The authors conclude that "a major component of assessing the public health impact of ENDS use is to understand the dependence potential". Why is this? They also propose that "methods for assessing dependence that can facilitate comparison across products are needed". Again they need to provide more explanation for why these think this is important. There were several results that I thought were interesting and that could have been mentioned. However, greater reference to the broader literature on vaping and other surveys of vapers would need to be included. Something different from other surveys of vapers was the higher proportion of females in this study. Comment: This is an interesting manuscript addressing a very important topic. Examining the use of ENDS, cigarettes and dual use among American Indians is somewhat novel, and with significant modifications, could have the potential to contribute to literature and knowledge on an important area of health equity and smoking cessation.
Response: We appreciate your thorough review of our manuscript. We have made significant modifications to the organization of the manuscript, the synthesis of the results, and the discussion. Our major changes include creating a more narrow purpose, removing data on secondhand smoke exposure, and re-ordering information in the methods and discussion sections. We hope that this new version, which reflects your helpful suggestions, is better fit for publication with BMJ open. Thank you.
Comment: This paper attempts to examine use and dependent measures for exclusive cigarette smokers, ENDS users, and dual-users (ENDS and cigarettes) in a convenience sample of American Indians living in the Southern plains region of the United States. As mentioned in the discussion section, the term "Southern Plains" is really incorrect for the current study and may actually encompass many more cultural and tribal groups than are represented by sampling in Oklahoma alone. I assume that this may have been done in an attempt to demonstrate that this population would fall into the "Southern Plains" category of tobacco prevalence mentioned in the introduction. However, I would suggest sticking with "American Indians residing in Oklahoma" for further descriptionparticularly because that offers more of a specific geographic portrayal to the reader. Since the state has a very large population of American Indian residents, this feels like a much more accurate and meaningful report.
Response: Thank you for this suggestion. We have corrected this throughout the manuscript.
Comment: The study states its purpose as addressing the lack of literature on ENDS use among American Indians by describing socio-demographic and lifestyle characteristics, secondhand smoke exposure, use behaviors and dependence among exclusive ENDS users, exclusive smokers, and dual users. The manuscript does not provide much detail on some of these items (lifestyle characteristics?). However, several interesting findings could be refined.
Response: We have narrowed the purpose based on your suggestion. "..we describe use behaviors and loss of autonomy, a core feature of dependence, in AI exclusive ENDS users and dual users of ENDS and cigarettes. We also present data on cigarette smokers of AI descent for comparison purposes.
Comment: Overall suggestions would be to remove the sections discussing "degree of Indian blood", all secondhand smoke (SHS) measures and other non-significant results, and instead focusing more heavily on fully discussing all findings within the context of an exploratory study. Since this is a study looking primarily at the use of ENDS by American Indian tobacco users, SHS feels like too distinctly different of a research question. Response: To focus on ENDs use behavior and dependence, we condensed the results and discussion regarding demographics and secondhand smoke exposure. Many of the variables could use a much stronger justification for why they were included as measurements.
Comment: It seems that the authors are considering exclusive smoking, dual use, and ENDS use to all be equally harmful activities. It would be helpful to see a recognition of what exactly dual use means, and why this would potentially be more dangerous than ENDS use alone, for example.
Response: We do not view ENDS to be equally as harmful as cigarettes. We are in agreement with the 2016 Surgeon General Report that states: E-cigarette aerosol is not harmless "water vapor," although it generally contains fewer toxicants than combustible tobacco products. We have added this to the introduction.
Comment: Finally, much of the discussion section would be more appropriate for the results (findings should not appear for the first time in the discussion section), and more detail could be given to the choices of assessment techniques (using PATH description for ENDS use; HONC for autonomy over cigarettes, etc.). Because there are so many wide-ranging research questions asked here, the study would benefit from stronger transitions throughout that work to create a more cohesive picture of what commercial tobacco use is like among this population.
Response: We have re-organized this per your suggestion.
Introduction:
Response: Thank you for this comment. We agree and have re-organized the introduction with the hope that is it more clear for the reader.
• The references for regional tobacco use rates are rather outdated… is there no newer data available?
Response: A more recent publication (Cobb 2014) with sex-specific prevalence estimates is available. However, after re-organizing this paper and re-focusing the purpose to an examination of ENDS use, we have decided not to include region specific smoking prevalence estimates.
• I would recommend against using the word "deemed" regarding the FDA and ENDS… particularly because this is an international journal, I'm not sure that the reader would immediately have the familiarity to know what this means.
Response: We reworded this and also provided a more clear description of what all is considered under the FDA regulatory authority: In August of 2016, the U.S. Food and Drug Administration Center for Tobacco Products (FDA CTP) was given the authority to regulate the manufacturing, distribution, and marketing of ENDS
Response: We hope that our new introduction is a better fit given the more focused study objective.
Response: Hopefully this is clearer now that we have re-organized the introduction.
• The paper refers to itself as "descriptive" several times in the methods and results, but seems to make larger claims about impact in the abstract and discussion sections (addressing the lack of literature; informing the FDA). Exploratory studies with small sample sizes (such as this one) are perfectly valid, but the description of it as such should be consistent.\ Response: We agree that our previous version made claims that would require an adequately powered study. We have highlighted that this is a small-scaled study in the abstract and discussion and have drawn back the bold claims.
Methods:
Response: Thank you for this comment. Since we were interested in recruiting individuals of AI heritage, and not those who just culturally identified with being AI, we also restricted our inclusion criteria to those with at least 2 asked grandparents of AI descent. This was done because genetics largely influence smoking behaviors and dependence.
• Was there a rationale for starting the cut-off at 10 CPD vs., 5 or even daily smoking? This may ultimately have an impact on the type of dual users that participate. There is no concern with 10 as the cut-off, but it might be helpful to add a supporting cite or brief statement on why this number was chosen for readers.
Response: We are interested in knowing if smokers, dual users, or ENDS users that are "regular users" differ in their use behaviors (and at a later date their biomarker levels). 5 CPD is a commonly used cutoff level for eligibility in clinical studies among smokers as it excludes those considered as 'chippers' who smoke daily, but infrequently, and have low dependence. Since we used this cutoff level in smokers, we also used this cutoff level in dual users. To clarify this in the paper, we added this sentence under the section titled 'Participant eligibility': Additional inclusion criteria was employed to result in a sample of "regular" users of cigarettes and/or ENDS. A regular cigarette smoker was defined as those who have smoked at least 5 cigarettes per day for the past 3 months…" We also wanted to be sure that we were not recruiting ENDS users who recently started using their device and so were inexperienced. As a result we required at least 3 months of regular use. We agree that our eligibility criteria is restrictive and results in a sample that is not generalizable to all dual users, as well as all exclusive ENDS users or smokers. We state this as limitation in the discussion.
Response: This was removed to avoid confusion.
Response: Thank you. At the time of the development of our questionnaire, this was few guidance or standards on how to approach defining a "regular" ENDS use, assessing ENDS dependence or frequency of use.
Response: We have moved these statements regarding the utility of HONC from the discussion section to the methods section.
Response: We added a more detailed explanation. Please see the section titled 'Biochemical assessment of smoking status'
Response: Thank you for this comment. They are not synonymous. Diminished autonomy is a core feature common to all forms of dependence, including tobacco dependence. We have clarified this throughout the paper.
Response: This has been clarified.
Response: We agree and have dropped this section to better reflect the study objective.
Response: Thank you for this suggestion. Although smoking behavior was not the primary focus of this paper, this table is informative for understanding dual use behavior and how it compares to exclusive smokers.
Response: The paper has been updated to reflect your suggestion.
